Edition:
United Kingdom

Dr. Lal Pathlabs approves acquisition of 70 pct stake in Dr. Lal Path Labs Bangladesh


Monday, 7 Aug 2017 

Aug 7 (Reuters) - Dr. Lal Pathlabs Ltd ::Says approved acquisition of a company in Bangladesh.Says co to acquire 70 percent stake in Dr Lal Path Labs Bangladesh Pvt Ltd for not more than 181.49 taka per share. 

Company Quote

1117.2
24.3 +2.22%
10:59am BST